News from the Faculty of Medicine in Bochum
Here you will find the latest news and press releases from the Faculty of Medicine at Ruhr University Bochum.
For older press releases, please take a look at our archive. Do you have questions about our faculty or would you like to report on us? Here you will find our press contact.
News
The Rectorate and the Faculty of Medicine of Ruhr University Bochum mourn the passing of Prof. Dr Walter Gehlen
Professor Gehlen made significant contributions to the further development of medical education at our Faculty, particularly during his term as Dean from 1991 to 1993. From his appointment to Ruhr University Bochum in 1984 until his retirement in 2004, he represented the field of neurology at Knappschaft Kliniken Universitätsklinikum Bochum and played a major role in shaping the development of the department. As a highly respected academic teacher, he inspired and supported generations of students and early-career researchers.
Prof. Dr. Katrin Marcus-Alic finds her own path in science
Prof. Dr. Katrin Marcus-Alic heads the Medical Proteome Center at RUB and combines research with science coaching. Her unconventional career has shaped an approach that also encourages young researchers to find their own path.
Klinikum Herford celebrates its 10th anniversary and invites the public to an Open Day
To mark its tenth anniversary, Klinikum Herford invites the public to an open day on 19 September. Visitors can experience university medicine up close, from robotic surgery to resuscitation and hands-on medical skills.
Online therapy helps with problematic internet use
LWL University Hospital Bochum is launching OMPRIS as a permanent online therapy programme for adults with problematic internet, gaming or smartphone use. The programme supports patients in changing their behaviour
Melanoma Research Advances Personalized Immunotherapy
A research project led by Dr. Christina Scheel explores how melanoma cells evade the immune system and why immunotherapies fail in some patients. The aim is to develop a test that better predicts treatment response and supports more individualized therapy decisions.
Alzheimer Biomarker P-tau217 shows Early Limitations
The biomarker p-tau217 is considered promising for early Alzheimer’s detection but shows surprisingly weak performance in preclinical stages. The study led by Prof. Dr. Gerwert challenges current assumptions and may influence the development of future diagnostic approaches.